e neonatal lupus syndrome consists of transient T cutaneous lupus lesions or permanent congenital complete heart block (or hepatic fibrosis), or both, occurring in a small percentage of infants born to mothers with systemic lupus erythematosus (SLE). The prevalence of connective tissue disease in mothers of babies with congenital complete heart block ranges from 33 to 64%. 12 Half of these women are symptomatic; the other half have only serologic evidence of connective tissue disease.3 In symptomatic mothers, SLE is the usual underlying disorder, but Sjogren syndrome, rheumatoid arthritis and undifferentiated connective tissue disease have also been found.2*4*5 In 1 study, the relation 'between maternal high-titer antibody and congenital complete heart block suggested a possible dose-response effect.6 However, the electrocardiograms of all the infants were not reported. Support for a dose-response relation would be increased, if more subtle conduction disturbances were detected by the electrocardiogram. This study examines the frequency of conduction abnormalities in offspring of mothers with SLE by identifying mothers with SLE rather than by identifying affected infants. Our hypothesis is that offspring of mothers with SLE would have a spectrum of conduction disturbances on the resting electrocardiogram ranging from first-degree atrioventricular block to the already recognized congenital complete heart block.
METHODS
In 1982 and again in 1988, women with SLE (1982 American Rheumatism Association revised criteria for SLE) followed in the Rheumatology Clinic at the University of Michigan were asked at the time of their regularly scheduled appointment if they had ever been pregnant. For each cohort (1982 [n = 321 and 1988 [n = 21]), women with children were later contacted by telephone and asked to participate in the study. Thirty-two of 42 mothers contacted in 1982 and 21 of 22 in 1988 agreed to participate in the study. In all, 84 of 92 living offspring of 53 women were evaluated. Except for 3 siblings who had elecnocardiograms obtained at a local hospital, electrocardiograms were recorded on a Cambridge VS-550 electrocardiographic recorder (frequency response, direct current to 100 Hz) with a heat writer on paper moving at 50 mm/s. Consent forms and questionnaires pertaining to the mother's and child's medical history were completed for each offspring. Anti-SSA/Ro and Anti-SSb/La antibody status was available from 25 mothers (18 from 1988, and 7 from 1982) . The study protocol, written consent forms and questionnaires for both cohorts were children have been published, are widely accepted and similar and were approved by the institutional review are constant over time, a contemporary control group board of the University of Michigan, was not necessary. We used standards published in 1980 Electrocardiographic intervals (Table I ) (heart rate, by Davignon et al7 that were derived from data in a popand PR, QRS and QT intervals) were measured inde-ulation of 2,141 children (age range 0 to 16 years) dividpendently by 2 investigators using a ruler calibrated to ed into 12 age groups. Age-dependent PR intervals and 0.5 mm. Because electrocardiographic standards for QRS duration percentiles, as well as distributions of Neg  19  13  79  140  80  350  20  Pns  Neg  20  6  89  110  50  300  21  Pos  Pos  21A  10  100  120  80  320  228  0.3  118  80  50  3001  22  NA  NA  22A  13  77  160  70  320  NA  NA  228  15  95  140  80  340  23  NA  NA  23  0.11  165  110  40  220  24  kz  Neg  24  0.13  200  80  40  220  25  NA  NA  25A  13  83  140  60  360  258  20  75  140  100  370  26  NA  NA  26  4  75  120  60  320  27  NA  NA  27  3  100  140  80  320  28  NA  NA  28~  4  95  140  70  300  NA  NA  288  12  82  120  70  370  NA  NA  28C  17  67  140  60  360  NA  NA  28D  21  78  150  60  340  29  Neg  W  29A  15  70  150  90  380  Neg  W  298  12  67  130  80  400  W  Neg  29c  9  65  160  80  380  30  NA  NA  30A  10  75  120  60  320  NA  NA  308  5  80  120  60  320  31  NA  NA  31A  11  60  120  70  380  32  Neg  Neg  32A  15  73  160  90  360  Neg  Neg  328  13  69  180  80  370$  33  NA  NA  33A  11  105  130  60  300  NA  NA  338  10  67  140  60  370  NA  NA  33c  9  107  120  70  300 *First-degree heart block for age or heart rate; tatrioventrcular dissociation with functional rhythm; thnt-degree atrioventricular block far both age and heart rate; gshort PR interval with no 8 wave, suggesting enhanced atrlovantricular :onduction. HR = heart rate; La-Ab = antl-La antibody; NA = not available: Neg = maternal antIbody not detectable; Pas = maternal 3ntibody present; PR = PR interval; Ro-Ab = anti-Ro antibody. 22  60  160  80  360  348  26  75  180  60  360*  34c  31  49  160   100   380  34D  28  77  140  80  400  35A  14  75  140  60  360  358  7  80  120  80  360  36  24  74  160  80  400  36A  15  75  140  100  370  368  14  75  160  100  330 68  120  60  400  47  14  96  140  80  360  48  32  70  150  60  340   49   28  77  140  70  360  50  12  114  160  60  310  51A  28  68  120  60  360  518  25  60  180  70  440  52A  14  75  130  90  320  52B  17  53  160  90  380  53  20  100  140  70  320 *First-degree heart block for age or heart rate; tatrioventricular dissociation with junctional rhythm: $first-degree atrioventricular block for both age and heart rate: §short PR interval with no 6 wave, suggesting enhanced atrloventrlcular conduction. HR = heart rate; La-Ab = anti-la antibody; NA = not available: Neg = maternal antibody not detectable; Pos = maternal antibody present; PR = PR interval; Ro-Ab = anti-R0 antibody. these values, from that study were used as the norma-RESULTS tive values in the present study. However, because of the wide range of normal PR intervals at different heart rates and ages ( Figures 3 and 4 from Davignon et al),7 each PR interval of the subjects in our study was assigned a rank order of 1 to 8 corresponding, in order, to a rank value <2nd percentile (rank value = l), between the 2nd and 5th, the 5th and 25th, the 25th and 5Oth, the 50th and 75th the 75th and 95th, and the 95th and 98th percentiles, and linally, >98th percentile (rank value = 8). The following 3 analyses were then perform& (1) comparison of the 1982 and 1988 data to determine if the cohorts differed, (2) comparison of all data to examine the effect of onset (before and during vs after pregnancy), as well as other variables; and (3) repetition of analysis 2 using only data from the eldest child to eliminate any intrafamily effects. Tests used to perform these analyses included l-way analysis of variance model, MannWhitney nonparametric test, &i-square test of independence, and analysis of co-variance and log-linear models. Differences were considered signiticant if the p value was 10.05.
In this group of 53 women with SLE, serologic results were known for 25 (Table I) . A woman was considered as having anti-SSA/Ro antibody if the antibody was found at any time. The rationale for this assumption is based on the reported occurrence of anti-SSA/Ro antibody before the onset of symptoms of SLE3 and because this antibody tends to remain present over prolonged periods of time.8 Of these 25 women, most (76%) were antinuclear antibody positive; 50% were anti-SSA/Ro antibody positive, and 56% were anti-SSB/La antibody positive. No mother had a child with congenital complete heart block.
The mean age of the offspring studied was 14.5 + 9.5 years. One-way analysis showed that the 1982 cohort was older (p = 0.05) and, as would thus be expected, had a slower heart rate (p = 0.04) than did the 1988 cohort. However, the electrocardiographic intervals did not differ significantly between the 2 groups. SLE was diagnosed before or during pregnancy in 28 cases and after pregnancy in the remaining 58. During 7 pregnancies, the mothers were treated with prednisone.
Analysis of electrocardiographic data (Table I) showed sinus rhythm in 85 of 86 offspring. A 16year-old male offspring had both intermittent atrioventricular dissociation and normal sinus rhythm, but normal atrioventricular conduction during sinus rhythm. Serologic data were not available from this subject's mother. One 20-year-old female offspring had right-axis deviation. The PR interval was ~95th percentile for age (i.e., normal) in 82 of 86 offspring and ~95th percentile for heart rate in 81. Three children had a PR interval >95th percentile (i.e., t&t-degree heart block) for both age and heart rate: A B-month-old male had a PR interval of 0.17 seconds at a heart rate of 136 beats/mm a 6-year-old male had a PR interval of 0.17 second at a heart rate of 100 beats/min, and a 13-year-old male had a PR of 0.18 second at a heart rate of 69 beats/min. Although 2 of the mothers of these 3 subjects developed SLE before or during the pregnancy, all 3 mothers' serum was devoid of anti-SSA/Ro and anti-SSB/La antibody. The PR interval of the other 6 subjects with lust-degree heart block for age or heart rate (i.e., 295th percentile) was 10.18 second. However, all offspring had intact atrioventricular conduction, and no other isolated electrocardiographic abnormalities were found.
In contrast to the individual data, grouped data suggested subtle effects of maternal SLE on atrioventricular conduction in offspring. Using the aforementioned rank assignment of PR intervals in relation to heart rate and age (and heart rate in relation to age), 2 differences were observed. First, heart rate adjusted for age was significantly (p = 0.003) higher in offspring whose mothers had the onset of SLE before or during pregnancy than in the normal population'; this difference was not present for children whose mothers developed SLE after pregnancy. Second, PR interval adjusted for heart rate (i.e., rank score indicating a difference in percentile level) was significantly (p = 0.0001) longer (i.e., score was greater) in offspring whose mothers developed SLE before or during pregnancy than in the normal population.' This difference was not present for subjects whose mothers developed SLE after pregnancy. These relations remained when only the eldest child was included in the analysis, supporting the likelihood of a difference related to SLE effects rather than to intrafamily effects. However, the data were insufficient to distinguish between the effects of age and onset of SLE (before and during vs after pregnancy) on PR interval. The analysis examining an antibody effect on PR interval produced no significant results, perhaps owing to a small number of women in whom antibody status was known.
DISCUSSION
In these 2 cohorts comprising 86 offspring of 53 mothers with SLE, we detected no isolated, significant, electrocardiographic abnormalities, even in children whose mothers were anti-SSA/Ro antibody positive. Fist-degree atrioventricular block was detected in 3 offspring; however, the 3 respective mothers were antibody negative during pregnancy, suggesting that in these cases the minor conduction abnormalities were probably unrelated to neonatal SLE. Similarly, the finding of an intermittent escape junctional rhythm in 1 adolescent offspring, as well as the right-axis deviation in another, probably represents a normal variant. However, the grouped data suggest that a subclinical effect of maternal SLE may be affecting the fetus and may contribute to a subtle delay in atrioventricular conduction in the fully developed infant or child.
Mechmwlti-neon&tll~otyt-8~8: Neonatal SLE syndrome is mediated by the transplacental passage (after the 12th to 16th week of gestation) of maternal immunoglobulin G antibodies to the fetus of a woman with SLE, followed by an immunologically-based intlammatory reaction (and/or deposition) of these antibodies with antigens of the fetal skin and heart, or botl-~.~,~~~,~--i~ Anti-SSA/Ro and anti-SSB/La antibodies to soluble tissue ribonucleoprotein antigens found in the cytoplasm or nucleus of human cells, or both,'O have been proposed as the etiologic agents of congenital complete heart block. t ' Demonstration of immunofluorescence from antibody deposition in cardiac tissue provides evidence that place&thy transmitted immunoglobulin G antibodies may act directly on the heart, producing deposition at the atrioventricular node, central fibrous body and fibrous annulu~.~~*~ Furthermore, Alexander et al*O have demonstrated an antibody (anti-SSA/Ro and anti-SSB/La)-mediated inhibition of neonatal rabbit cardiac repolarization, indicating a direct effect on the electrophysiologic properties of developing excitable tissue. All these observations are compatible with a dose-response effect of maternal antibodies on immature atrioventricular conduction tissue.
Risk to fetus: In a retrospective study of offspring of women with SLE, Ramsey-Goldman et al6 described 16 infants with congenital complete heart block in 96 pregnancies of women who had anti-SSA/Ro antibody. In contrast, only 1 infant in 235 pregnancies of women with SLE but without anti-SSA/Ro antibody had neonatal SLE. In that study, the overall risk of a woman with SLE having an infant with congenital complete heart block was estimated to be 1:60 (when corrected for referral bias), but the risk was considerably greater (1:20) if anti-SSA/Ro antibody was present. Buyon et al*l have described maternal antibodies from the mothers of neonatal SLE infants to specific peptides of the ribonuclear SSA/Ro complex, as well as to the SSB/La particle; both of these peptides are abundant in fetal cardiac tissues. The presence of antibodies to these specific peptides increases the risk ratio of a mother with SLE giving birth to an infant with neonatal lupus by a factor of 35.
Clinical impliii
The incidence, reduced morbidity and improved survival of women of childbearing age affected by SLE renders pregnancy in these cases an important clinical problem. This study was retrospective. Thus, transient conduction disturbances in the neonatal period may have been overlooked. However, the study underscores the strong possibility of subclinical alterations in atrioventricular conduction in some fetuses exposed to a maternal SLE environment, and thus supports a dose-response relation between atrioventricular conduction in the fetus and infant and maternal SLE antibodies. However, because of bradycardia noted in the newborn at birth, congenital high-grade or complete heart block is usually recognized and confirmed by electrocardiography. Thus, if the heart rate of a fetus or newborn whose mother has SLE is normal, neither early obstetric intervention nor routine postnatal electrocardiograms are necessary.
